Matthew E Korenberg has an estimated net worth of $18.3 Million. This is based on reported shares across multiple companies, which include LIGAND PHARMACEUTICALS INC, Qualigen Therapeutics, Inc., PALVELLA THERAPEUTICS, INC., and LIFECORE BIOMEDICAL, INC. \DE\.

2024 was Matthew E Korenberg's most active year for acquiring shares with 12 total transactions. Matthew E Korenberg's most active month to acquire stocks was the month of January. 2024 was Matthew E Korenberg's most active year for disposing of shares, totalling 26 transactions. Matthew E Korenberg's most active month to dispose stocks was the month of August. 2024 saw Matthew E Korenberg paying a total of $1,123,220.76 for 285,492 shares, this is the most they've acquired in one year. In 2024 Matthew E Korenberg cashed out on 102,185 shares for a total of $7,826,727.84, their largest year based on trade value.